Literature DB >> 14578693

Developmental trajectories of cocaine-and-other-drug-exposed and non-cocaine-exposed children.

Linda C Mayes1, Domenic Cicchetti, Suddhasatta Acharyya, Heping Zhang.   

Abstract

Few data are available concerning the trajectories of mental and motor development across time for cocaine-exposed children compared with others. Findings are presented from individual group curve analyses of the mental and motor development measured by the Bayley Scales of Infant Development-II (BSID-II) on repeated visits from 3 through 36 months of a group of prenatally cocaine-and-other-drug-exposed children (n = 265) compared with those exposed to no drugs (n = 129) or no-cocaine-but-other-drugs (n = 66), including alcohol and/or tobacco. Across time, there was a general decline in motor performance but cocaine-exposed-infants showed a trend toward a greater decrease than children in the other two comparison groups. For mental performance, there was also a decline across age but only through 24 months and no differences in the trajectory of the cocaine-exposed group compared to the other two. And, across all assessment ages, cocaine-exposed-infants showed lower BSID-II mental performance compared to both non-drug and non-cocaine-exposed children. Results suggest that prenatally cocaine-exposed children show delayed developmental indices, particularly in their mental performance, but their trajectories across time are similar to those from impoverished, non-cocaine-exposed groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578693     DOI: 10.1097/00004703-200310000-00003

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  20 in total

1.  Neurobehavioral and Developmental Traiectories Associated with Level of Prenatal Cocaine Exposure.

Authors:  Claudia A Chiriboga; Louise Kuhn; Gail A Wasserman
Journal:  J Neurol Psychol       Date:  2014-11

Review 2.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Adolescent risk-taking as a function of prenatal cocaine exposure and biological sex.

Authors:  Jedediah W P Allen; David S Bennett; Dennis P Carmody; Yiping Wang; Michael Lewis
Journal:  Neurotoxicol Teratol       Date:  2013-12-12       Impact factor: 3.763

5.  Trajectories of cognitive development among American Indian young children.

Authors:  Christina M Mitchell; Calvin Croy; Paul Spicer; Karen Frankel; Robert N Emde
Journal:  Dev Psychol       Date:  2011-07

6.  Infant birth outcomes among substance using women: why quitting smoking during pregnancy is just as important as quitting illicit drug use.

Authors:  Beth A Bailey; Judy G McCook; Alexis Hodge; Lana McGrady
Journal:  Matern Child Health J       Date:  2012-02

7.  Prenatal cocaine exposure: an examination of childhood externalizing and internalizing behavior problems at age 7 years.

Authors:  Veronica H Accornero; James C Anthony; Connie E Morrow; Lihua Xue; Emmalee S Bandstra
Journal:  Epidemiol Psichiatr Soc       Date:  2006 Jan-Mar

Review 8.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

9.  Prenatal Cocaine Exposure and Motor Performance at 4 Months.

Authors:  Rosemarie Bigsby; Linda L LaGasse; Barry Lester; Seetha Shankaran; Henrietta Bada; Charles Bauer; Jing Liu
Journal:  Am J Occup Ther       Date:  2011-09

10.  Risk-taking and the feedback negativity response to loss among at-risk adolescents.

Authors:  Michael J Crowley; Jia Wu; Clifford Crutcher; Christopher A Bailey; C W Lejuez; Linda C Mayes
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.